{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:37:55Z","timestamp":1790257075912,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.parkreldis.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:26:58Z","timestamp":1473424018000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinical heterogeneity of LRRK2 p.I2012T mutation"],"prefix":"10.1016","volume":"33","author":[{"given":"Tian-Sin","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Meei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hwei","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-I.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.09.008_bib1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/432422","article-title":"LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century","volume":"77","author":"Lesage","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.20886","article-title":"Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries","volume":"21","author":"Tomiyama","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","article-title":"Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation","volume":"16","author":"Luz\u00f3n-Toro","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","article-title":"Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes","volume":"15","author":"Hasegawa","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.62.1.82","article-title":"Parkin mutations and early-onset parkinsonism in a Taiwanese cohort","volume":"62","author":"Wu","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000335167.72412.68","article-title":"Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore","volume":"71","author":"Lin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00439-011-1041-6","article-title":"Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria","volume":"130","author":"Lin","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11373-008-9260-0","article-title":"LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies","volume":"15","author":"Lin","year":"2008","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib15","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1093\/hmg\/ddu203","article-title":"Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations","volume":"23","author":"Guerreiro","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1353-8020(97)00013-8","article-title":"German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - longitudinal observations","volume":"3","author":"Wszolek","year":"1997","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","article-title":"Parkinsonism, Lrrk2 G2019S, and tau neuropathology","volume":"67","author":"Rajput","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.09.008_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-006-0178-1","article-title":"Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions","volume":"113","author":"D\u00e4chsel","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib22","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/ana.10572","article-title":"Epidemiology and genetics of frontotemporal dementia\/Pick's disease","volume":"54","author":"Bird","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.parkreldis.2014.06.004","article-title":"Parkinsonian syndrome in familial frontotemporal dementia","volume":"20","author":"Siuda","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib25","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11033-014-3111-z","article-title":"Structural and functional in silico analysis of LRRK2 missense substitutions","volume":"41","author":"Cardona","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib26","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1523\/JNEUROSCI.1737-10.2010","article-title":"LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3\u03b2","volume":"30","author":"Lin","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20070209","article-title":"LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity","volume":"405","author":"Jaleel","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2016.09.008_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","article-title":"Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation","volume":"7","author":"Wider","year":"2010","journal-title":"Neurodegener. Dis."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016303339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016303339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T12:56:45Z","timestamp":1536411405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016303339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"alternative-id":["S1353802016303339"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.09.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical heterogeneity of LRRK2 p.I2012T mutation","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}